Focusing on Solid Dosage Trends and Demand

Find out more about key trends shaping solid dosage drug development and manufacturing and the changing demands impacting the market. Furthermore, gain a greater understanding about how coating design has evolved over the years and how regulatory requirements are affecting solid dosage developers and manufacturers.

Register Free: https://www.pharmtech.com/pt_w/solid-dosage-trends

Event Overview:

In this exclusive Drug Digest video interview, Felicity Thomas, Associate Editorial Director, Pharmaceutical Technology Group, interviews experts about solid dosage drug development and manufacturing. During the discussion, expert(s) will provide an overview of the solid dosage drug development and manufacturing sector, factors driving growth in the market, challenges facing companies and the shifts in demand, the evolution of coating design, and regulatory considerations impacting oral solid dosage development and manufacturing.

Key learning Objectives:

• Learning about trends shaping the solid dosage drug development and manufacturing market
• Understanding the challenges facing solid dosage development and manufacturing
• Learning about the changing demand within the solid dosage development and manufacturing field
• Highlighting the evolution of coating design for oral solid dosage forms
• Discovering regulatory requirements impacting oral solid dosage development and manufacturing

Who Should Attend:

• Solid dosage drug developers
• Solid dosage drug manufacturers
• Formulation scientists
• Quality personnel
• CDMOs
• Development scientists

Speaker:

Dr. Ali Rajabi-Siahboomi
Vice President and Chief Innovation Officer
Colorcon

Ali Rajabi-Siahboomi is the vice president and chief innovation officer at Colorcon, based at the Global Headquarter, USA. Rajabi-Siahboomi has held various academic positions in Nottingham and Liverpool JM Universities in the UK before joining Colorcon as technical director, responsible for Europe, the Middle East, and Africa in 2000. His main research interests are solid dosage form pharmaceutics, pharmaceutical technology with emphasis on oral drug delivery systems, solubility enhancement to improve bioavailability, and consistency of drugs and bioequivalence formulations. He has published more than 300 articles, book chapters, abstracts, and patents and obtained his B.Pharm. and PhD in pharmacy from the University of Nottingham (UK).

Register Free: https://www.pharmtech.com/pt_w/solid-dosage-trends